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Summary Both asthma and obesity have become more common in affluent societies
during the recent decades and several studies have shown a correlation between the
presence of asthma and obesity.
In order to further study this association we have investigated a population from a
community in southern Sweden, where almost all inhabitants had their body indices
measured as part of a study on diabetes at a primary care centre. An asthma unit
working with a structured care programme for asthma was available. This
organisation enabled us to study whether body mass index and waist circumference
was associated with having or developing asthma.
There was a significant association between both overweight, increased waist
circumference and asthma, Po0.01. The risk for developing asthma was associated
with increased body weight and abdominal circumference, Po0.05. The increase in
asthma morbidity in the overweight subjects was found almost exclusively in the
non-atopic asthma patients.
This study confirms earlier findings of an increased prevalence of asthma in obese
and overweight patients. Increased obesity and especially abdominal obesity is thus
a risk factor for asthma, which probably contributes to the high prevalence of
asthma in affluent societies.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Asthma has shown an increased prevalence since at
least the 1960s and prevalence figures of up to 10%
have been reported in Sweden.1 A full explanation
for this increase has not been found. Hereditary
factors are basic for the disease development but
the rapid increase in prevalence indicates that
external factors such as environment and lifestyle
are important. Several such factors have been
investigated and discussed e.g. exposure to airway
irritants such as tobacco smoke, changes in micro-
bial colonisation of the gut and dietary changes.
Obesity and overweight have also become more
common in affluent societies during the recent
decades.2,3 In the metabolic syndrome the fat
distribution seems to be important and it is excess
of central fat that is related to the increased
morbidity.4,5 Recently several studies have shown a
correlation between the presence of obesity and
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symptoms.6–14 The association could be that the
respiratory symptoms make the patients more
prone to a sedentary life and thus causing an
increase in body weight. Two studies employing
questionnaires indicate that overweight precedes
the asthma diagnosis.15,16 Other explanations are
that the fat tissue could have pro-inflammatory
effects17,18 or that dietary factors are of impor-
tance for both conditions.19,20
In the Kinda municipality comprising about 10 000
inhabitants in southern Sweden a unique investiga-
tion of the prevalence of overweight and abdominal
obesity was performed in 1992 and 1993. In 1994,
the primary care centre of the community started
an asthma unit in which patients with a suspicion of
having asthma were evaluated using a structured
care program for asthma management. In most
cases an allergy work up was performed. The
weight investigation and the files at the asthma
unit offered a possibility to investigate the number
of asthmatics in various body mass index (BMI)
groups and also to study the incidence of asthma in
relation to overweight indices. Since most asth-
matics were classified with regard to atopy it was
possible to see whether obesity was related to
allergic sensitisation.
Materials and methods
The Kinda municipality is 40–80 km south of Link-
.oping in south-eastern Sweden. There are two
larger villages from which people commute to
Link .oping, but the majority work in local industries
or in farming or forestry. The population has been
stable for the last 20 years with a population of
10 500 in 1992 and of 10 100 in 2000. There is one
primary care centre which most patients attend;
severe and emergency cases are seen at the
regional hospital, which is Link .oping University
Hospital.
A diabetes treatment programme has been
running at the primary centre since the late
1980s. A screening programme of the prevalence
of overweight and obesity in the population was
performed in 1992–1993.21 All grown up inhabitants
in Kinda community were invited to participate.
The subjects were weighed without shoes but with
ordinary indoor clothes. Height was measured using
a measuring stick and abdominal circumference
was measured with a tape midway between arcus
costae and crista iliaca after exhalation. In this way
almost 90% of the population had their height,
weight, abdominal and hip circumferences mea-
sured. BMI was calculated according to the formula
weight in kg/height in m2. The subjects were
divided in four classes according to the BMI values:
underweighto20, normal 20–o25, overweight 25–
o30 and obese X30. Waist circumferences were
categorised in three classes in each sex according
to Lean:22 females class 1: o80 cm, class 2: 80–
87.9 cm, class 3: X88 cm; males class 1: o94 cm,
class 2: 94–101.5 cm and class 3: X102 cm.
The asthma unit with a qualified asthma nurse
was established in 1994 with one of the authors (U
N K) in charge for the first years. The main task was
the diagnosis and treatment of asthma and patients
with asthma-like symptoms were referred. The
asthma unit worked with a quality-controlled
asthma care programme.23 Diagnosis of asthma
was based on symptoms and signs with the help of
home monitoring of peak expiratory flow and
spirometry including a test for reversibility to b2-
agonists. In many patients an allergy test with
specific IgE measurements was performed. In some
cases a skin prick test was done at the referral
hospital.
For this investigation two of us (OZ and UNK)
together went through the files at asthma unit for
the years 1995–2000 and identified patients be-
tween 20 and 50 years of age with a diagnosis of
asthma. The upper limit of 50 years was chosen in
order to avoid including patients with chronic
obstructive pulmonary disease in the material. We
extended our search to the university hospital
records in order to find patients from the district
who had been seen only at the hospital.
To qualify for the diagnosis of asthma the patient
should demonstrate at least one of the following
criteria:
* Documented variability in peak expiratory flow
of at least 20% under a period of home
monitoring, morning and evening, for 2 weeks.
* Reversibility after inhaled b2-agonist in peak
expiratory flow of at least 20% or in forced
expiratory volume in 1 s (FEV1) of at least 15%.
* A positive exercise challenge. A fall in peak
expiratory flow of at least 20% or in FEV1 of at
least 15% after physical exercise.
* A positive effect of a steroid course, i.e. a rise in
FEV1 of 15% or in peak expiratory flow of 20%
after treatment with inhaled steroids or after a
short course (6–12 days) of steroids orally.
In addition, we included in our search patients
referred to the asthma unit during the same time
span with doubtful or slight symptoms charac-
terised as not having asthma in the original work
up. These patients were asked in a questionnaire
whether they still had symptoms and if so they
were offered a new investigation at the Allergy
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Centre in the University hospital. Twenty-seven
patients were re-investigated with spirometry,
reversibility tests and in most cases with a
challenge with forced inhalation of dry air.
Statistics
Differences between groups were calculated with
Chi2-test in Microsoft Excel. Relative risk ratios (RR)
and P-values for trend assessments were made with
binomial regression using Stat v7 (Stata Corp,
College Station, TX, USA 2000).
Results
At the time of the weight screening was performed
in the Kinda district, there were 4178 persons 20–
50 years of age of whom 2025 were women and
2153 were men. Data on weight were available for
3281 (78.5%) of them, (women 83%, men 74%). In
the diagnosis register at the primary care centre we
found 146 patients with asthma (83 women and 63
men) during the time period 1995–2000. Anthropo-
metric data was recorded in 109 patients. Nine
additional patients (7 women and 2 men) were
identified through re-investigation of the 27
patients who had been at the asthma unit in Kinda
between 1995 and 2000 but at that time they were
not classified as asthma. A telephone interview was
made with 47 patients with a diagnosis of asthma
but for whom we thought when scrutinising their
files that their asthma diagnose were uncertain. Of
these patients, 17 were excluded because they did
not justified the criteria for asthma. The calcula-
tions are thus made on 101 patients with a certain
diagnosis of asthma, 62 women and 39 men. Of
them 38 had got their diagnosis since 1992 (24
women and 14 men). Of the men 18 out of 39 were
considered to be atopic and of the women 24 out of
62. Six of the men were smokers and seven were
ex-smokers. Of the women with asthma 14 were
still smoking while seven were ex-smokers.
In the whole group of asthmatic patients 57.4%
were overweight or obese while the corresponding
number in the non-asthmatic group was 44.9%. This
difference is significant, Chi2 P¼ 0.012. The corre-
lation between obesity and asthma was highly
significant in women, Chi2 P¼ 0.002, while in men
the relation was not significant, Chi2 P¼ 0.46.
The distributions in BMI classes in asthmatics and
non-asthmatics are given in Figs. 1 and 2. There is a
higher percentage of asthmatic females in the
higher BMI classes. As for men there is a trend to
increased asthma occurrence only in the obese
category. Chi2 P¼ 0.057. The relation between
abdominal circumference and asthma was stronger
than between BMI and asthma. In non-asthmatics
14.5% had an increased circumference, while
among asthmatic patients the figure was 27.7%.
This difference is significant Chi2 P¼ 0.001. The
difference was also significant here in women Chi2
P¼ 0.01, while in men it was non-significant Chi2
P¼ 0.1. By allocation of the patient material in the
various BMI-classes, see Table 1, a significant trend
for increased risk for asthma with increasing BMI
could be calculated, P¼ 0.01. The RR for asthma in
the obese group was 2.24. A similar trend was also
seen if abdominal circumference was related to
occurrence of asthma. The relative risk for asthma
in the group with abdominal obesity was 2.09, P for
trend¼ 0.006.
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Figure 1 Distribution in BMI-classes in asthmatic and non-asthmatic women. BMI class 1: BMI o20, class 2: BMI 20–
o25, class 3: BMI 25–o30, class 4: BMIX30.
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Incidence of asthma
Both increased BMI and abdominal obesity in 1992–
1993 was associated with an increased risk of
getting an asthma diagnosis during 1995–2000. RR
for the obese was 2.37 (P¼ 0.05) and RR for
abdominal obesity 2.6 (P¼ 0.01), see Table 4.
Trend calculations showed a non-significant trend
for BMI, P¼ 0.07, but a significant trend, P¼ 0.02,
for waist circumference.
Abdominal obesity seemed to be a slightly higher
risk factor for newly developed asthma than BMI;
this was most evident in men, in whom an
abdominal circumference of more than 102 cm
resulted in a five-fold risk of developing asthma,
P¼ 0.01.
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Figure 2 Distribution in BMI-classes in asthmatic and non-asthmatic men. BMI class 1: BMI o20, class 2: BMI 20–o25,
class 3: BMI 25–o30, class 4: BMIX30.
Table 1 Relative risk for asthma depending on BMI and waist circumference.
Women and men RR P Conf. interval P for trend RR P Conf. interval P for trend
Asthma
BMI 1 1.50 0.32 0.68–3.32
BMI 2 1 M1 1
BMI 3 1.50 0.07 0.96–2.33 M2 0.89 0.66 0.51–1.53
BMI 4 2.24 0.00 1.31–3.85 0.01 M3 2.09 0.00 1.35–3.25 0.006
Men
Asthma
BMI 1 0.00 0.99
BMI 2 1 M1 1
BMI 3 0.99 0.98 0.49–1.99 M2 1.05 0.91 0.47–2.34
BMI 4 2.01 0.10 0.87–4.62 0.13 M3 2.13 0.05 0.99–4.55 0.1
Women
Asthma
BMI 1 1.81 0.17 0.78–4.18
BMI 2 1 M1 1
BMI 3 2.25 0.01 1.27–4.0 M2 0.80 0.56 0.37–1.70
BMI 4 2.46 0.01 1.21–5.02 0.03 M3 1.97 0.01 1.15–3.39 0.04
BMI 1: o20, BMI 2: 20–o25, BMI 3: 25–o30, BMI 4: X30.
Women waist class M1: o80 cm, M2: 80–87.9 cm, M3: X88 cm.
Men waist-class M1: o94 cm, M2: 94–101.5 cm, M3: X102 cm.
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Relation to atopy
Patients with asthma and with a positive skin prick
test, a raised concentration in serum for specific
Immunoglobulin E or a history of typical allergic
rhinoconjunctivitis was diagnosed as having atopic
asthma. In this group there was no significantly
increased risk for asthma with increasing BMI or
abdominal circumference, see Table 2. In contrast,
there was an evident correlation for the occurrence
of non-atopic asthma both to increased BMI
(RR¼ 2.56, P¼ 0.01, P for trend 0.009) and to
abdominal obesity (RR 2.85, P¼ 0.0005, P for trend
0.001), see Table 3. The increased risk was
significant for both sexes for obesity measured as
waist circumference.
Analysis of excluded patients
In 17 cases, where the patient primarily had been
given a diagnosis of asthma this could not be
verified. Of these, eight patients had another
disease affecting lung function such as allergic
alveolitis and myasthenia gravis and four were
healthy after the initial disease period. In another
five cases we could not find the patients for a
telephone interview. Mean values of BMI and
abdominal circumference in these cases did not
differ from the patients still remaining in the study.
If the excluded patients were added to the
calculations no significant differences could be
shown.
Discussion
In this primary care area the prevalence of asthma
according to the primary care register was 3.5%
(146/4178) in the group 20–50 years of age which
may seem low.
However, it is well known that there is a
difference between an epidemiological prevalence
of asthma which now in Sweden is about 8% and
what is found in studies of patients seeking medical
care for respiratory symptoms where the preva-
lence figures are 2–4%. In a previous survey of
asthma care in our county ( .Osterg .otland), the
asthma prevalence in the primary care units was
about 2%.24 The prevalence figures found in this
investigation are thus in accordance with what has
been reported previously.
The incidence in our study was relatively low
with 38 new cases in 5 years i.e. 7.6 cases/year
corresponding to an incidence of about 0.2%. This is
low compared to the incidence in northern Sweden
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Table 2 Relative risk for atopic asthma depending on BMI and waist circumference.
Men and women RR P Conf. interval P for trend RR P Conf. interval P for trend
Atopic asthma
BMI 1 2.64 0.09 0.86–8.11
BMI 2 1 M1 1
BMI 3 2.49 0.01 1.23–5.04 M2 0.98 0.97 0.45–2.16
BMI 4 1.86 0.24 0.66–5.25 0.23 M3 1.37 0.43 0.62–3.0 0.51
Men
Atopic asthma
BMI 1 0.00 0.99 0.00
BMI 2 1 M1 1
BMI 3 1.92 0.20 0.71–5.17 M2 0.72 0.62 0.21–2.55
BMI 4 0.69 0.73 0.08–5.67 0.52 M3 1.33 0.66 0.38–4.66 0.86
Women
Atopic asthma
BMI 1 3.62 0.04 1.03–12.67
BMI 2 1 M1 1
BMI 3 3.33 0.02 1.22–9.11 M2 1.27 0.65 0.46–3.49
BMI 4 3.20 0.07 0.91–11.21 0.24 M3 1.37 0.54 0.50–3.78 0.51
BMI 1: o20, BMI 2: 20–o25, BMI 3: 25–o30, BMI 4: X30.
Women waist class M1: o80 cm, M2: 80–87.9 cm, M3: X88 cm.
Men waist-class M1: o94 cm, M2: 94–101.5 cm, M3: X102 cm.
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of 0.5–0.8 reported by R.onnmark in the OLIN-
studies.25 In these studies the incidence was mainly
based on questionnaires sent to a large population.
Our lower incidence figures might be explained by
the fact that we had strict criteria for an asthma
diagnosis.
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Table 4 Relative risk for developing asthma depending on BMI and waist circumference.
Men and women RR P Conf. interval P for trend RR P Conf. interval P for trend
New asthma
BMI 1 1.07 0.93 0.25–4.64
BMI 2 1.00 M1
BMI 3 1.34 0.43 0.65–2.76 M2 0.58 0.32 0.20–1.69
BMI 4 2.37 0.05 1.01–5.54 0.07 M3 2.60 0.01 1.32–5.12 0.02
Men
New asthma
BMI 1 0.00 0.99 0.00
BMI 2 1.00 M1 1.00
BMI 3 1.58 0.48 0.45–5.57 M2 2.30 0.21 0.62–8.51
BMI 4 4.04 0.05 1.02–15.99 0.04 M3 5.21 0.01 1.52–17.84 0.005
Women
New asthma
BMI 1 1.00 1.00 0.22–4.49
BMI 2 1.00 M1 1.00
BMI 3 1.47 0.40 0.60–3.63 M2 0 0.98
BMI 4 1.75 0.33 0.56–5.45 0.29 M3 1.8 0.17 0.78–4.12 0.44
BMI 1: o20, BMI 2: 20–o25, BMI 3: 25–o30, BMI 4: X30.
Women waist class M1: o80 cm, M2: 80–87.9 cm, M3: X88 cm.
Men waist-class M1: o94 cm, M2: 94–101.5 cm, M3: X102 cm.
Table 3 Relative risk for non-atopic asthma depending on BMI and waist circumference.
Men and women RR P Conf. interval P for trend RR P Conf. interval P for trend
Non-atopic asthma
BMI 1 0.67 0.59 0.16–2.82
BMI 2 1.00 M1 1.00
BMI 3 1.20 0.55 0.66–2.15 M2 1.32 0.42 0.68–2.57
BMI 4 2.56 0.01 1.34–4.90 0.009 M3 2.85 0.0005 1.61–5.04 0.001
Men
Non-atopic asthma
BMI 1 0.00 0.99 0.00
BMI 2 1.00 M1 1.00
BMI 3 0.43 0.15 0.13–1.35 M2 1.44 0.50 0.50–4.18
BMI 4 2.80 0.03 1.08–7.26 0.13 M3 3.13 0.03 1.15–8.51 0.03
Women
Non-atopic asthma
BMI 1 0.79 0.76 0.18–3.45
BMI 2 1.00 M1 1.00
BMI 3 2.28 0.02 1.12–4.62 M2 1.31 0.54 0.55–3.08
BMI 4 2.38 0.06 0.97–5.82 0.011 M3 2.57 0.01 1.29–5.14 0.01
BMI 1: o20, BMI 2: 20–o25, BMI 3: 25–o30, BMI 4: X30.
Women waist class M1: o80 cm, M2: 80–87.9 cm, M3: X88 cm.
Men waist-class M1: o94 cm, M2: 94–101.5 cm, M3: X102 cm.
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In 17 of 118 patients we could not verify and
dismissed the initial asthma diagnosis. In a study in
Gothenburg in Sweden 13 of the patients who
initially got an asthma diagnosis could not be
verified as having asthma.26 Through the use of a
structured asthma care programme throughout the
period of the study, the follow up of data in the
patient files and telephone check-ups we are
relatively sure of the asthma diagnosis in our cases.
In comparison to the earlier reported large
register studies this study is small, still it show
similar results with a doubled or three-folded risk
of asthma for obese individuals. In addition to a
strict asthmadiagnosis study personnel performed
the measurements of height, weight and abdominal
circumference. These values are probably more
exact than if the patients provide the data
themselves, as was done in most of the earlier
studies.
A possible confounding factor would be socio-
economic status since there is a higher prevalence
of obesity in subjects with a low income. However,
we have not found any obviously deviation in
income or profession in the asthmatic group
compared to the community group.
In this study, as in earlier studies16,27,28 the
relation between BMI and asthma was more evident
in women than in men. In our study, we have also
included abdominal circumference and there was a
significantly increased risk for asthma in both
women (P¼ 0.01) and men (P¼ 0.05) with abdom-
inal obesity. Men with abdominal obesity also had
an increased risk of developing asthma. Waist
circumference in relation to asthma has been
investigated in one previous study comprising only
women.15 In that study there was no relation
between asthma and waist circumference.
The importance of obesity for asthmatic symp-
toms is strongly supported by the positive effect of
weight loss on the respiratory symptoms as was
described after operation with gastric banding29 or
after controlled dietary measures as in the studies
from Finland.30,31
What could mediate this relationship between
asthma and obesity? Many explanations have been
offered including low physical activity as a common
factor. In our study, as in two other longitudinal
studies,15,16 we have shown that increased weight
can precede the development of asthma, which
means that an explanation based on the presump-
tion that asthma gives a sedentary life and there-
fore leads to increased obesity is not valid.
Likewise the theory that obese people have a
lifestyle with a lot of time spent indoors leading to
increased exposure for allergen is not supported by
our results. We did not see any correlation between
atopy and overweight; on the contrary the relation
between obesity and asthma was almost exclusively
confined to the non-atopic subgroup. Similar find-
ings have been reported in most studies7,11,32,33
with the exception of one study from Taiwan6 in
which teenage girls with overweight had an
increased risk for atopy.
There are certain changes in respiratory physiology,
at least in heavily overweight patients, which might
explain some of the airway symptoms.34,35 The
decrease in lung function could be due to mechanical
compression of the thorax leading to a lower tidal
volume and less stretching of bronchial muscles
leading to an increased responsiveness in the airways.
When lung volumes are small it might cause even sub
clinical asthma symptoms to become evident. The
lung volumes ought to be most affected by visceral
fat which is most easily evaluated by measuring the
waist circumference. Abdominal obesity has also
recently been shown to lead to a more pronounced
decrease in forced vital capacity (FVC) and in forced
expiratory volume in one second (FEV1) in men than
in women.36 Hakala has in a recent study investigated
the lung function in obese asthmatics and how it was
affected by weight loss. A clear increase in FVC was
seen but the highest increase was seen in expiratory
residual volume (ERV). This resulted in a better FEV1
and also a better flow rate at the middle part of FVC
(FEF25–50).
30
The distribution of fat is different in women and
men and this might explain why the relation
between asthma and BMI is most evident in
women.37 In this study abdominal circumference
as a measure of obesity correlated better to asthma
than BMI in both sexes. BMI might not be the best
instrument for relate asthma to overweight, espe-
cially among men, who can have a high BMI due to a
high muscle mass. If the relation between asthma
and overweight is due to the metabolically active
fat tissue, it would be better to measure waist
circumference than BMI.
An alternative explanation to the importance of
abdominal fat is that visceral fat may produce pro-
inflammatory mediators like IL6 that in animal
models has been shown to give subepitelial fibrosis
and airway remodelling.38 In overweight people
signs of a general inflammation such as elevated
CRP-levels have been shown.39 Leptin, which is
increased in fatness also upregulates immunologi-
cal defence.40 Also weight gain by itself might leads
to an increased risk for asthma. In the normative
aging study14 an increase in weight was associated
with asthma even in those who were in the normal
weight range. The immunological activity of fat
tissue might be most important when fat tissue is
increasing.
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During recent decades when the prevalence’s of
both asthma and overweight have increased the
changes in the western type of food have also been
extensive. The content of fat has increased and
there has been a change in the balance of free fatty
acids. Food with high fat content and low content
of antioxidants may lead to obesity.19 The in-
creased prevalence of allergic disease in children
has been related to the content of n-6 and n-3
polyunsaturated fatty acids in the food.41
Further studies of the importance of nutritional
factors in asthma are mandated.
Conclusion
This and other studies support the fact that there is
a relationship between asthma and overweight and
that obesity in itself is a risk factor for developing
asthma. Probably, this connection is most influ-
enced by the centrally located fat tissue. By
treatment of obesity and overweight and by
prophylaxis of weight increase we have got a
possibility for the asthmatic patients to reduce his
or hers respiratory symptoms and for the healthy to
diminish the risk of developing asthma.
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